AzTrials
AzTrials

Renal Stone DiseaseNCT07864194

Direct In-Scope Suction Versus Standard Flexible Ureterorenoscopy

A study testing Standard flexible ureterorenoscope and Flexible ureterorenoscope with direct in-scope suction in people with Renal Stone Disease, run by Hitit University at 1 site in Turkey (Türkiye).

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This prospective study aims to compare the clinical, perioperative, and postoperative outcomes of flexible ureterorenoscopy using a direct in-scope suction system (DISS) with standard flexible ureterorenoscopy in patients undergoing retrograde intrarenal surgery for renal or proximal ureteral stones. Read more about this study

Who is it for?
Ages 18 to 75 years
Conditions the study is for
Renal Stone Disease
What is being tested?
Standard flexible ureterorenoscope and Flexible ureterorenoscope with direct in-scope suction
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
70 participants
Where
1 siteTurkey (Türkiye)
Study dates
7 Jul 2026to 15 Nov 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 75 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Adults aged 18 years or older.
  • A single stone located in the kidney or proximal ureter.
  • Scheduled to undergo retrograde intrarenal surgery (RIRS) by the study's surgical team.

Who cannot join

  • Multiple renal or proximal ureteral stones.
  • Age younger than 18 years.
  • Pregnancy.
  • Preoperative urinary tract infection.
  • Bleeding diathesis.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

MUSTAFA SERDAR ÇAĞLAYAN contact

+90 507 431 1951

serdar.09.09@hotmail.com

Turkey (Türkiye)1 site, 1 recruiting
  • Department of Urology, Hitit University Çorum Erol Olçok Training and Research Hospital, Çorum, Türkiye

    Çorum, Çorum, 19040

    AHMET TAŞCI, 05531596690, ahmettasci400@gmail.com

    AHMET TAŞCI

    Recruiting

Other trials in Turkey (Türkiye)

About this study

Official title: Flexible Ureterorenoscope With Suction: An Innovative Approach

This prospective study aims to compare the clinical, perioperative, and postoperative outcomes of flexible ureterorenoscopy using a direct in-scope suction system (DISS) with standard flexible ureterorenoscopy in patients undergoing retrograde intrarenal surgery for renal or proximal ureteral stones. A total of 70 patients will be enrolled, with 35 patients in each group. The study will assess postoperative infectious complications, including fever, systemic inflammatory response syndrome (SIRS), and sepsis, as well as operative parameters, length of hospital stay, reoperation, and stone-free status. Stone-free status will be assessed by non-contrast computed tomography four weeks after surgery.

Read the detailed description

Retrograde intrarenal surgery (RIRS) is used to treat renal and proximal ureteral stones. During flexible ureterorenoscopy, stone fragments and irrigation fluid may impair visualization, and elevated intrarenal pressure may contribute to postoperative infectious complications. Direct in-scope suction (DISS) permits aspiration through the ureterorenoscope during irrigation and lithotripsy. This study will compare procedural and postoperative outcomes with and without DISS.

This single-center, prospective, randomized, parallel-group study will enroll 70 adults undergoing RIRS at Erol Olçok Training and Research Hospital. Participants will be assigned in a 1:1 ratio to standard flexible ureterorenoscopy or DISS-equipped flexible ureterorenoscopy using a computer-generated randomization sequence. Each group will include 35 participants. Clinical data will be collected during surgery and postoperative follow-up.

The standard group will undergo surgery using a 7.5 Fr Storz Flex-X2 flexible ureterorenoscope. The DISS group will undergo surgery using a 7.5 Fr single-use Claritron flexible ureterorenoscope with direct in-scope suction. Both groups will use a 9.5/11.5 Fr ureteral access sheath, guidewire, Holmium:YAG laser lithotripsy, and normal saline irrigation. Procedures will be performed under general anesthesia in the lithotomy position, with the irrigation bag positioned approximately 100 cm above the patient.

Eligible patients will be aged 18 years or older and undergo RIRS by the same surgical team for a single renal or proximal ureteral stone. Patients with multiple stones, pregnancy, preoperative urinary tract infection, or bleeding diathesis will be excluded.

Demographic and stone characteristics, operative time, fluoroscopy time, total laser energy, length of hospital stay, and need for reoperation will be recorded. Laboratory results, including white blood cell count, C-reactive protein, and creatinine, as well as urine and blood culture results when obtained, will be collected during follow-up.

The primary outcomes are postoperative fever, systemic inflammatory response syndrome (SIRS), and sepsis. Fever is defined as a body temperature >38°C within 48 hours after surgery. SIRS is defined as the presence of at least two of the following: temperature >38°C or <36°C, heart rate >90 beats/min, respiratory rate >20 breaths/min, or white blood cell count >12,000/mm³ or <4,000/mm³. For this protocol, sepsis is defined as SIRS with suspected or confirmed infection. For patients who develop infectious complications, treatment, intravenous antibiotic use, and intensive care requirements will be recorded.

Secondary outcomes include stone-free status on non-contrast computed tomography approximately four weeks after surgery, postoperative changes in white blood cell count and creatinine, and postoperative culture findings. Residual fragments ≤4 mm will be classified as clinically insignificant for the study's stone-free assessment.

The two groups will be compared using tests appropriate for the distribution and type of each variable. Categorical data will be reported as counts and percentages. A p value <0.05 will be considered statistically significant.

Being tested
Standard flexible ureterorenoscope, Flexible ureterorenoscope with direct in-scope suction
Keywords
Retrograde intrarenal surgery (RIRS), Kidney stone, Infectious complications, Urinary tract infection, Sepsis
Medical subject headings
Kidney Calculi, Urinary Tract Infections, Sepsis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Standard flexible ureterorenoscopeDevice

    A 7.5 Fr reusable Storz Flex-X2 flexible ureterorenoscope without direct in-scope suction will be used for retrograde intrarenal surgery. Stone fragmentation will be performed with a Holmium:YAG laser through a 9.5/11.5 Fr ureteral access sheath.

  • Flexible ureterorenoscope with direct in-scope suctionDevice

    A 7.5 Fr single-use Claritron flexible ureterorenoscope equipped with direct in-scope suction will be used for retrograde intrarenal surgery. Suction through the scope will be available during irrigation and Holmium:YAG laser lithotripsy. A 9.5/11.5 Fr ureteral access sheath will be used.

Study groups in NCT07864194
Study groupRoleWhat they receive
Standard Flexible UreterorenoscopyActive comparatorParticipants randomized to this arm will undergo retrograde intrarenal surgery using a 7.5 Fr Storz Flex-X2 flexible ureterorenoscope without direct in-scope suction. A 9.5/11.5 Fr ureteral access sheath, Holmium:YAG laser lithotripsy, and normal saline irrigation will be used.
Receives: Device: Standard flexible ureterorenoscope
Direct In-Scope Suction Flexible UreterorenoscopyExperimentalParticipants randomized to this arm will undergo retrograde intrarenal surgery using a 7.5 Fr single-use Claritron flexible ureterorenoscope equipped with direct in-scope suction. A 9.5/11.5 Fr ureteral access sheath, Holmium:YAG laser lithotripsy, and normal saline irrigation will be used.
Receives: Device: Flexible ureterorenoscope with direct in-scope suction

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Incidence of Postoperative Fever

    Number and percentage of participants with a recorded body temperature >38°C within 48 hours after surgery.

    Measured: Within 48 hours after surgery

Secondary outcomes (3)
  1. Incidence of Postoperative Systemic Inflammatory Response Syndrome

    Number and percentage of participants meeting at least two of the following criteria: temperature >38°C or <36°C, heart rate >90 beats/min, respiratory rate >20 breaths/min, or white blood cell count >12,000/mm³ or <4,000/mm³.

    Measured: Within 48 hours after surgery

  2. Incidence of Postoperative Sepsis

    Number and percentage of participants with suspected or confirmed infection who also meet the protocol-defined systemic inflammatory response syndrome criteria.

    Measured: Within 48 hours after surgery

  3. Stone-Free Rate

    Number and percentage of participants with no residual stone or residual fragments ≤4 mm on non-contrast computed tomography.

    Measured: 4 weeks after surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Oct 2026
  2. Study start7 Jul 2026
  3. Primary completion30 Oct 2026 (estimated)
  4. Study completion15 Nov 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
70 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07864194
Sponsor's protocol ID
ETIK-2026-34
Status last verified
Sep 2026
First submitted
27 Sep 2026
Last updated
7 Oct 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Patel PU, Uy M, Dauw C, Sui W, Plott J, Roberts WW, Ghani KR. Direct in-scope suction (DISS) ureteroscopy: techniques, outcomes and future directions. BJU Int. 2026 Mar;137 Suppl 3(Suppl 3):S19-S28. doi: 10.1111/bju.16871. Epub 2025 Aug 5.

    PubMed 40763000

Questions about this trial

What is this clinical trial studying?

A study testing Standard flexible ureterorenoscope and Flexible ureterorenoscope with direct in-scope suction in people with Renal Stone Disease, run by Hitit University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 7 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact MUSTAFA SERDAR ÇAĞLAYAN (+90 507 431 1951, serdar.09.09@hotmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Incidence of Postoperative Fever (time frame: Within 48 hours after surgery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07864194, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in